About the 4th Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit (#EGeneCell)

Introduction

Join us at the forefront of gene and cell therapy innovation at the 4th Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit, taking place on June 4-5, 2025, in Vienna, Austria. The #EGeneCell 2025 summit is dedicated to accelerating progress in the Chemistry, Manufacturing, and Controls (CMC) and quality development of gene and cell therapy (GCT) products.

This premier event is an essential gathering for industry leaders, scientists, and regulatory experts who are driving the evolution of gene and cell therapies. Participants will gain valuable insights into strategies for meeting Cellular and Gene Therapy Products (CGTP) safety and efficiency criteria, adhering to stringent regulatory and Good Manufacturing Practice (GMP) standards, and optimizing vector production processes.

Why Attend?

At the #EGeneCell 2025 Summit, you'll explore cutting-edge technologies and innovative processes that are poised to revolutionize the manufacturing of gene and cell therapies. This includes the integration of digital solutions and automation, along with the application of sophisticated Critical Quality Attributes (CQAs) that ensure the highest standards of product quality and efficacy.

Key Practical Learning Points

• Accelerating Gene and Cell Therapy Development:

Gain insights into the latest advancements in the development of GCT products, with a focus on enhancing CMC and quality processes. Learn from experts about the best practices and innovative approaches that are driving progress in this rapidly evolving field.

• Ensuring CGTP Safety and Efficiency:

Discover strategies for ensuring consistent safety and efficiency standards for CGTPs. Understand the regulatory requirements and GMP manufacturing protocols that are essential for compliance and successful product development.

• Optimizing Vector Production:

Learn how to optimize and scale vector production processes to improve performance and efficacy. Explore new methodologies and technologies that are enhancing vector manufacturing and overcoming current production challenges.

• Embracing New Technologies:

Dive into the latest technological innovations that are transforming the manufacturing of gene and cell therapies. From automation and digital solutions to advanced CQAs, discover how these tools are driving greater efficiency, reliability, and quality in GCT production.

Insights and Critical Issues from the Industry

The gene and cell therapy industry is at a critical juncture, facing a unique set of challenges and opportunities:

Regulatory Hurdles:

Navigating the complex regulatory landscape remains one of the most significant challenges. Regulatory agencies are continually updating guidelines, and staying compliant requires constant vigilance and adaptation.

Manufacturing Scalability:

As therapies move from clinical trials to commercial production, scaling up manufacturing processes without compromising quality is a critical issue. The summit will address strategies for scalable and cost-effective manufacturing solutions.

Supply Chain Management:

Ensuring a reliable and efficient supply chain for raw materials and components is essential. The industry faces challenges related to supply chain disruptions and the need for robust logistics to support production.

Cost and Accessibility:

The high cost of gene and cell therapies poses a barrier to widespread accessibility. Discussions will focus on innovative approaches to reduce production costs and make therapies more affordable.

Quality Control and Assurance:

Maintaining high standards of quality control and assurance is paramount. The development of more sophisticated CQAs and real-time monitoring technologies is essential for ensuring product consistency and safety.

Technological Integration:

Integrating advanced technologies such as AI, machine learning, and automation into manufacturing processes can significantly enhance efficiency and precision. The summit will explore how these technologies can be effectively implemented.

What to Expect

Attendees of the #VLGeneCell 2025 Summit can look forward to a dynamic and interactive program, featuring:

• Expert-Led Presentations: Hear from leading researchers and industry experts who will share their knowledge and experiences in gene and cell therapy manufacturing.
• Panel Discussions: Engage in thought-provoking discussions with peers and experts on the key challenges and opportunities in the field.
• Networking Opportunities: Connect with other professionals, exchange ideas, and build collaborations that can drive your projects forward.
• Technology Showcases: Explore the latest products and solutions from top technology providers that are shaping the future of gene and cell therapy manufacturing.

Join Us

The #EGeneCell 2025 Summit is your opportunity to stay at the cutting edge of gene and cell therapy development. Whether you are looking to enhance your knowledge, stay updated on the latest regulatory standards, or explore new technologies and processes, this summit is the place to be.

Take a chance to be part of a transformative event that will influence the future of gene and cell therapies. Register now to secure your place at the #EGeneCell 2025 Summit in Munich, Germany, and join the leaders and innovators driving the next generation of GCT advancements.